PRGS · Progress Software Corporation · Stock research

Current Thesis

Progress runs a disciplined software roll-up the "Total Growth Strategy" of buying mature, high-renewal infrastructure software, integrating hard, and compounding free cash flow. Two fresh catalysts just re-rated a sleepy compounder: the Q2 FY2026 beat plus full-year guide raise (2026-06-30) and the $400M acquisition of Domo (2026-07-22). The M&A-special-situations theme is active, and the equity broke out +11.7% on the print. This is a MATURING, low-beta name whose narrative velocity is real but modest the cleaner entry is a pullback to the breakout retest, not the extended tape.

Bullish and bearish views on Progress Software Corporation

The model's bull view on Progress Software Corporation (PRGS), in brief: Q2 FY2026 (reported 2026-06-30): adjusted EPS $1.62 beat the $1.49 estimate; revenue $253.465M beat $242.741M a double beat. The bear view: GAAP EPS guide was LOWERED to $1.60–$1.74 (from $1.71–$1.87) vs $1.75 est on the same 2026-06-30 update. Both cases follow in full.

Bull Case

• Q2 FY2026 (reported 2026-06-30): adjusted EPS $1.62 beat the $1.49 estimate; revenue $253.465M beat $242.741M a double beat.
• FY2026 adjusted EPS guide raised to $6.09–$6.21 (from $5.91–$6.03) vs $5.98 consensus; revenue guide raised to $990M–$1.002B vs $994.1M est (2026-06-30).
• Stock rose 11.7% on 2026-07-01, breaking out of a multi-quarter base.
• Domo acquired for $400M (announced 2026-07-22), roughly ~1.3x revenue on a struggling standalone BI/analytics platform a cheap, accretive tuck-in that adds Domo.AI agentic analytics to the portfolio.
• Serial-acquirer record: MarkLogic ($355M, 2023), ShareFile (~$875M from Citrix, 2024), Nuclia (agentic RAG). Recurring revenue sits above ~80% with high renewal rates and strong FCF conversion.
• AI-adjacency is accumulating: Progress Chef now delivers enterprise lifecycle management for NVIDIA DGX Spark (2026-06-30); MarkLogic plus Nuclia form an enterprise agentic-RAG stack.
• Analyst re-rating in motion: DA Davidson maintains Buy, PT raised to $45 (2026-07-23); Oppenheimer Outperform, PT $50 (2026-07-01). Stock trades below both.
• Capital return runs alongside M&A quarterly dividend plus buybacks.

Bear Case

• GAAP EPS guide was LOWERED to $1.60–$1.74 (from $1.71–$1.87) vs $1.75 est on the same 2026-06-30 update. The widening gap between adjusted and GAAP EPS is the real cost of the roll-up acquisition amortization and integration expense.
• Q3 FY2026 GAAP EPS guide of $0.35–$0.41 sits below the $0.43 estimate.
• The model runs on perpetual leverage: net debt steps up with each deal and FCF services debt as much as it funds growth. A higher-for-longer rate regime raises the cost of the entire machine.
• Organic growth is low single digits; acquired growth can mask a stagnating core.
• Domo was a serially disappointing public company integration, culture, and AI-talent retention are live risks on a $400M bet.
• Low beta, thin retail interest, modest narrative velocity. The 11.7% pop plus the deal-day move may be most of the near-term move already spent.

Setup & Price Structure

• Post-earnings breakout 2026-07-01 (+11.7%) cleared a multi-quarter base; the Domo announcement on 2026-07-22 stacked a second catalyst leg on top.
• Price sits below both active analyst targets ($45 DA Davidson, $50 Oppenheimer), leaving room on the re-rating so long as the base holds.
• Short-term extended after two catalysts landed inside three weeks. A MATURING compounder of this profile usually hands back a cleaner entry on a retest of the breakout shelf / rising 20-EMA rather than rewarding a chase into strength.
• Gap support sits around the 2026-07-01 post-earnings pivot; losing that fills the gap and voids the setup.
• Low realized volatility sizing should respect that momentum velocity here is muted and the payoff profile is a special-situation grind, not a squeeze.

Catalyst Calendar (next 30 days)

• ~2026-08 (est): Domo merger proxy and HSR antitrust clearance filings expected; a Domo shareholder vote follows.
• ~2026-08 (est): next quarterly dividend declaration / ex-date.
• Ongoing analyst re-rating post-Domo (DA Davidson $45 and Oppenheimer $50 have already moved; watch for further target revisions).
• Domo deal expected to close in 2H 2026 (est), pending shareholder vote and regulatory clearance.
• Next earnings Q3 FY2026, fiscal quarter ending 2026-08-31 lands ~2026-09-24 (est), OUTSIDE the 30-day window; no earnings blackout applies right now.

What Would Change Our Mind

• A weekly close that fills the 2026-07-01 gap and loses the breakout shelf.
• The Domo transaction terminating or drawing a regulatory block.
• Deal cadence stalling while the M&A-special-situations theme rolls to saturated with no visible target pipeline.
• Organic revenue (ex-acquisition) turning negative the signal that the roll-up is papering over core decay.
• Net leverage spiking into a tightening rate regime, forcing a pause in the acquisition engine.

Correlation Notes

• Moves with the software-consolidator cohort Constellation Software, Roper, Open Text quality roll-ups that re-rate and de-rate together on rate expectations.
• Rate-sensitive by construction: the leveraged acquisition model correlates inversely with the 10Y and real yields.
• Domo (DOMO) is now a merger-arb proxy trading to the deal spread; PRGS carries the acquirer-side risk and integration overhang.
• Second-order AI-infra beta via Chef/NVIDIA DGX Spark and the MarkLogic/Nuclia agentic-RAG stack, but small relative to the deal narrative.
• Low correlation to high-beta AI momentum baskets; the profile reads defensive-compounder rather than a QQQ momentum proxy.